An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3) the identification of drugs new to DAWN’s Drug Reference Vocabulary.
Dashboard: Filter Bricks
Main page content
This guide explains prescription drug monitoring programs (PDMPs), and how they can enhance clinical decision making. The guide also explains how PDMP improves patient safety, while helping to decrease prescription drug misuse and unintentional overdose deaths.
This NSDUH report discusses trends in the prevalence of mental illness, substance use disorders, or both among adolescents and adults in the United States.
This quick guide helps clinicians address the specific needs of women living with substance use disorders. It reviews gender-specific research and best practices—such as common patterns of misuse—and specific screening and treatment strategies.
This quick guide helps administrators of substance use disorder treatment facilities implement programs and services that address the needs of women living with substance use disorders. It addresses patterns of use and the drug screening and treatment needs of women.
This guide equips clinicians with information for treating chronic pain in adults living with a history of substance use. The guide discusses chronic pain management, including treatment with opioids. It also includes information about substance use assessments and referrals. Access the literature review.